• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, October 30, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Inflammatory burden at admission runs lower in heart attacks with unblocked arteries, multicenter study finds

by
October 30, 2026
in Health
Reading Time: 3 mins read
0
Inflammatory burden at admission runs lower in heart attacks with unblocked arteries, multicenter study finds

Inflammatory burden at admission runs lower in heart attacks with unblocked arteries, multicenter study finds

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Patients whose heart attacks occur without any blocked coronary artery appear to carry a measurably lighter inflammatory load on arrival at hospital than patients whose attacks stem from obstructive coronary disease, according to a multicenter retrospective observational study published in BMC Cardiovascular Disorders. The researchers used a composite measure called the admission inflammatory burden index, or IBI, calculated by multiplying high-sensitivity C-reactive protein by the neutrophil-to-lymphocyte ratio, and found that lower values were associated with the non-obstructive phenotype known as MINOCA.

This multicenter retrospective observational study screened 5,746 patients with acute myocardial infarction undergoing coronary angiography. The final cohort included 247 patients with MINOCA after clinical, angiographic, and cardiac magnetic resonance evaluation, alongside a computer-generated random sample of 525 patients with myocardial infarction with obstructive coronary artery disease (MICAD).

The association between systemic inflammatory burden and MINOCA had remained unclear before this work. The association between systemic inflammatory burden and MINOCA remained unclear, and the study evaluated this association using the admission IBI. IBI levels were indeed lower in patients with MINOCA than in those with MICAD, a difference that reached statistical significance with a P value below 0.001.

In logistic regression analyses, lower IBI was associated with the MINOCA phenotype. In unadjusted logistic regression, lower IBI was associated with the MINOCA phenotype with an odds ratio of 0.599 and a 95 percent confidence interval of 0.527 to 0.678, with P below 0.001. After multivariable adjustment, the association persisted, though attenuated, with an odds ratio of 0.813, a 95 percent confidence interval of 0.697 to 0.949, and a P value of 0.009. The association was attenuated after multivariable adjustment compared with the unadjusted analysis.

Restricted cubic spline analysis added a nonlinear dimension to the finding, showing an overall association with P below 0.001 and a P value for nonlinearity below 0.001, meaning the relationship between IBI and the MINOCA phenotype was not a simple straight-line effect. Quartile analysis, which divided patients into four groups by IBI level, showed attenuation in the highest quartile, with a P value for trend of 0.047. The authors reported that the findings were generally consistent across predefined subgroup and sensitivity analyses, suggesting the result is robust to different ways of slicing the data.

The authors themselves framed the conclusions cautiously. Lower admission IBI was associated with the MINOCA phenotype, they wrote, and these findings indicate differences in admission inflammatory burden between myocardial infarction phenotypes and should be considered hypothesis-generating. The authors stated that these findings indicate differences in admission inflammatory burden between myocardial infarction phenotypes and should be considered hypothesis-generating.

Subject of Research: Association between admission inflammatory burden index and myocardial infarction with non-obstructive versus obstructive coronary arteries

Article Title: Admission inflammatory burden index in myocardial infarction with non-obstructive versus obstructive coronary arteries: a multicenter observational study

Article References: Xu, C., Xu, C., Gu, P., Chen, W., Wang, T., Li, D., Zhang, J., Liu, T., Zhang, Q., Jing, Z., Ding, J., & Xue, Z. (2026). Admission inflammatory burden index in myocardial infarction with non-obstructive versus obstructive coronary arteries: a multicenter observational study. BMC Cardiovascular Disorders. https://doi.org/10.1186/s12872-026-06935-x

Image Credits: AI Generated

DOI: 10.1186/s12872-026-06935-x

Keywords: MINOCA, inflammatory burden index, C-reactive protein, neutrophil-to-lymphocyte ratio, coronary angiography, cardiac magnetic resonance, multicenter observational study, logistic regression, restricted cubic spline, acute myocardial infarction, Admission, inflammatory

News Source: Ophelia Keating. (October 30, 2026). Inflammatory burden at admission runs lower in heart attacks with unblocked arteries, multicenter study finds. Scienmag.

Tags: Acute Myocardial InfarctionAdmissionC-reactive proteincardiac magnetic resonancecoronary angiographyinflammatoryinflammatory burden indexlogistic regressionMINOCAmulticenter observational studyNeutrophil-to-lymphocyte ratiorestricted cubic spline
Share12Tweet7Share2ShareShareShare1

Related Posts

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

October 30, 2026
Most Ethiopian HIV patients on dolutegravir therapy show good knowledge, survey finds

Most Ethiopian HIV patients on dolutegravir therapy show good knowledge, survey finds

October 30, 2026

Serum and urine protein biomarkers may sharpen prostate cancer detection beyond PSA

October 30, 2026

One gene locus flags atrial fibrillation risk after major surgery, UK Biobank study finds

October 30, 2026

POPULAR NEWS

  • Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

    Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

    29 shares
    Share 12 Tweet 7
  • Firebreaks Leave Lasting Scars in Grasslands While Wildfire Heals Fast

    29 shares
    Share 12 Tweet 7
  • ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

    29 shares
    Share 12 Tweet 7
  • Systematic review maps sustainability tensions in offshore wind development

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

Firebreaks Leave Lasting Scars in Grasslands While Wildfire Heals Fast

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 86 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.